BridgeMD
New treatment option for Food Protein Induced Enterocolitis Syndrome (FPIES)
Official title A Multicentre French Prospective Study of Children With Food Protein Induced Enterocolitis Syndrome in Its Acute Form
ClinicalTrials.gov ID: NCT05528900
What this study is testing
- What it's testing
- Food protein induced enterocolitis syndrome (FPIES), is a non-IgE mediated food allergy (FA) which seems to expand, and occurring in infancy. This disease is usually unknown by clinicians.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 17
You may be able to join if
- age from 0 to 17 years old,
- seen in allergologist visit for acute FPIES, due to history of suggestive clinical symptoms, confirmed by the criteria published in 2017 in the JACI...
- affiliated to social security (public healthcare system)
- signed consent of one of the parents or the holder of parental authority
You likely can't join if
- Associated pathology that may contraindicate OFC at the discretion of the investigating physician. In particular justifying permanent treatment with...
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Aulnay-sous-Bois, France
- Clermont-Ferrand, France
- Colmar, France
- Grenoble, France
- Haguenau, France
- Lille, France
- Lyon, France
- Montpellier, France
- Nancy, France
- Nice, France
- Paris, France
- Rouen, France
- Toulouse, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Aulnay-sous-Bois, France; Clermont-Ferrand, France; Colmar, France; Grenoble, France; Haguenau, France and 8 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.